NCT00733551
- Conditions
- Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
- Locations
-
- GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom
Clinical trial condition
Gastroparesis
Explore clinical trials studying Gastroparesis. Study availability and eligibility vary by location and protocol.
193 public trials
40 recruiting studies
Gastroparesis trial results
Completed
Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes
NCT02324010
- Conditions
- Diabetes Mellitus, Digestive System Diseases, Endocrine System Diseases, +10 more
- Locations
-
- University of Adelaide, Discipline of Medicine, Royal Adelaide Hospital Adelaide, South Australia, Australia
NCT01294566
- Conditions
- Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia
NCT01039974
- Conditions
- Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
NCT01267071
- Conditions
- Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
- Locations
-
- GSK Investigational Site Nottingham, United Kingdom
NCT01469286
- Conditions
- Diabetic Gastroparesis, Digestive System Diseases, Gastrointestinal Diseases, +9 more
- Locations
-
- University of Mississippi Jackson, Mississippi, United States
- Texas tech university health science center El Paso, Texas, United States
NCT00370084
- Conditions
- Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
- Locations
-
- University of Adelaide, Department of Medicine Adelaide, South Australia, Australia
NCT01602549
- Conditions
- Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia
- GSK Investigational Site Ulm, Baden-Wurttemberg, Germany
- GSK Investigational Site Bochum, North Rhine-Westphalia, Germany
- GSK Investigational Site Bonn, North Rhine-Westphalia, Germany
Completed
Erythromycin in Parkinson's Disease
NCT02005029
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
- Locations
-
- Virginia Commonwealth University Parkinson's Center Richmond, Virginia, United States
Completed
Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance
NCT01039805
- Conditions
- Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
- Locations
-
- GSK Investigational Site Adelaide, South Australia, Australia